NCT05212896View on ClinicalTrials.gov

An Exploratory Clinical Study of BC006 in Patients With Advanced Solid Tumors

PHASE1UnknownINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

November 26, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Advanced Solid Tumors (Including GCTTS)
Interventions
DRUG

BC006

BC006 monoclonal antibody injection

Trial Locations (1)

200000

RECRUITING

Dragonboat Biopharmaceutical,Co.,Ltd, Shanghai

Sponsors
All Listed Sponsors
collaborator

West China Hospital

OTHER

lead

Dragonboat Biopharmaceutical Company Limited

INDUSTRY